Cellink AB (publ)

(CLKKF, OTCGREY)

$9.03

+$0.00
(+0.00%)
PE Ratio
0.00
EPS
$0.00
Market Cap
$98M
52 Week Range
$0.00 - $0.00
Operating Margin
0.00%
Dividend & Yield
$0.00 (0.00%)
Volume
NaN
Rev. per Share
$0.00

About Cellink AB (publ)

Cellink AB (publ) designs and develops bioprinting technologies that enable researchers to 3D print organs and tissue for applications primarily in pharmaceutical to cosmetic industries worldwide. It offers bioprinters, imaging systems, dispensing solutions, and bioinks in the field of academic and clinical medicine for labs and scientists worldwide. The company's bioprinting solutions include BIO X, a bioprinter for life-science companies, researchers, and innovators; BIO X6, a bioprinting platform for printing complex structures; INKREDIBLE and INKREDIBLE+, which are bioprinting solutions for skin, cartilage tissue, and others; Holograph X, a solution that leverages high-resolution holographic stereolithography to bioprint small structures; Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures, and others; and tool heads and print heads. It also offers biofluidics solutions, which include I-DOT, a solution for liquid-handling tasks; single-cell printer, an automated laboratory instrument; c.sight, a single-cell dispensing technology for cell line development and single-cell genomics; b.sight, a solution that enables prokaryotic cell isolation in the sub-micron range; and f.sight, a solution that dispenses unlabeled and fluorescent cells. The company offers bioinks for various applications, such as drug screening, tissue models, tissue regeneration, organoids, immunotherapy, microfluidics, scaffolds, encapsulation, wound healing, cosmetics, educational models, and others; CELLCYTE X, a live cell microscopy imaging system; and accessories, such as consumables, needles, and nozzles. Its customers also include universities, hospitals, and public and commercial laboratories. Cellink AB (publ) has a collaboration with MedImmune; and strategic partnership with Made In Space, Inc. It also offers products online. The company was founded in 2016 and is based in Gothenburg, Sweden.

Earnings

News about Cellink AB (publ)

Cellink AB (publ)

Type
Sector
Other
Industry
Other
About kinfo
Kinfo is an app for DIY traders and investors. Kinfo tracks your trading performance and lets you compare measurable performance metrics against other traders. Kinfo works for day trading, swing trading and longer holding periods. By tracking portfolio performance kinfo allows traders to learn, find inspiration and gain confidence.
Get Social
Download the App

Trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.

Never risk more than you are willing to lose. Trading futures and other derivatives may cause losses that exceed deposits.

Hypothetical performance results have inherent limitations, some of which are described below. Kinfo makes no representation that any trading account will or is likely to achieve profits or losses like those shown. There are often sharp differences between hypothetical trading performance results and the actual results subsequently achieved by any trading program. Past results of advertised trading systems, profit statements, charts or any other representations are not indicative of future performance.

Kinfo is an educational site and is not a financial adviser or broker. All stocks, ETFs, commodities, Indices, Forex, Bonds, and other securities mentioned in our courses are for educational and illustrative purposes only. If you need professional investment advice, please consult a registered investment adviser. Futures and Options carry risk and may not be suitable for everyone.

Kinfo demonstrates specific advanced approaches (or methods). Any mention of Return of Investment percentages is only indicative of the potential of the strategy or the system and is not meant to signify any guaranteed returns.

Success in trading involves a range of human factors like decision making skills, adjustment skills, emotional control, and risk management and other psychological and behavioral parameters, all of which are completely in the hands of the individual. Trading involves significant risk of loss. It is not suitable for all investors.

Charts on kinfo provided by TradingView